GHRS News and Press, GH Research PLC From 11/01/21

Gainers: ABVC BioPharma (NASDAQ:ABVC) +250%, ANI Pharmaceuticals (NASDAQ:ANIP) +51%, Artelo Biosciences (NASDAQ:ARTL) +37%, Nutriband (NTRBW) +34%, Regencell Bioscience (NASDAQ:RGC) +15%. Losers: Centessa Pharmaceuticals (NASDAQ:CNTA) -19%, Mi...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The resilient U.S. stock market racked up another round of record highs on Friday, as investors looked past disappointing quarterly results f...

Gainers: Cadence Bancorporation (NYSE:CADE) +43%. A10 Networks ATEN +30%. GH Research (NASDAQ:GHRS) +25%. Retail Value (NYSE:RVI) +23%. WiMi Hologram WIMI +23%. Greenidge (NASDAQ:GREE) +19%. Aspen Aerogels ASPN +18%. Bel Fuse BELFB +18%. Ramaco Resources (NASDAQ:METC) +16%...

Psychedelic biopharmaceutical company GH Research PLC (NASDAQ: GHRS) saw its shares pop over 15% in trading after the company was named in a hedge fund purchase. Mark Lampert’s Biotechnology Value Fund initiated $200 million worth of brand new positions in depression drug-f...

DUBLIN, Ireland, Sept. 23, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided business updates and reported financial results for the second qua...

Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +155%, Edesa Biotech (NASDAQ:EDSA) +34%, Atea Pharmaceuticals (NASDAQ:AVIR) +20%, Synlogic (NASDAQ:SYBX) +13%, Viveve Medical (NASDAQ:VIVE) +9%. Losers: BeyondSpring (NASDAQ:BYSI) -22%, Protagonist Therap...

The WHO predicts that depression will be the biggest problem in the world during the next decade and beyond. GH Research had a rather successful IPO on the 24th of June. Investing in biotech may be the way to go for investors looking for large gains over the long term. For f...

This is Psychedellux – the week’s top business headlines in the psychedelics industry. Dublin-based GH Research is now listing its stock on the Nasdaq under the symbol “GHRS” after opening for trading on Friday, July 2 at $22. The company ...

GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the treatment of psychiatric and neurological disorders, is now listing its stock on the Nasdaq under the symbol “GHRS” after opening for trading on Friday, July 2 at $22. The company had...